Table 2.
Estimated RR of TB mortality from a main effects model using binomial log-linear regression (n = 93 133)
| RR | (95 % CI) | |
|---|---|---|
| HIV status | ||
| Negative | Ref | |
| Positive | 2.19 | (2.03–2.37) |
| Unknown | 1.86 | (1.57–2.21) |
| Age group | ||
| 15–24 years | Ref | |
| 25–34 years | 1.44 | (1.28–1.63) |
| 35–44 years | 1.93 | (1.70–2.18) |
| 45–54 years | 2.95 | (2.64–3.30) |
| 55–64 years | 4.75 | (4.12–5.48) |
| 65+ years | 9.16 | (7.79–10.78) |
| Baseline smear | ||
| Negative | Ref | |
| Positive | 0.88 | (0.82–0.94) |
| No smear | 1.25 | (1.13–1.37) |
| Disease classification | ||
| PTB | Ref | |
| EPTB | 1.14 | (1.04–1.26) |
| Both | 1.30 | (1.10–1.55) |
| Gender | ||
| Female | Ref | |
| Male | 1.06 | (1.01–1.12) |
| Type of treatment | ||
| New | Ref | |
| Retreatment | 1.34 | (1.24–1.44) |
| Year | ||
| 2009 | Ref | |
| 2010 | 0.92 | (0.86–0.99) |
| 2011 | 0.83 | (0.76–0.90) |
| 2012a | 0.83 | (0.74–0.93) |
RR relative risk, CI confidence interval, TB tuberculosis, PTB pulmonary TB, EPTB extra-pulmonary TB
aOnly the first 6 months of 2012 were included in this analysis